DM
Devang Manharlal Ajmera
About Devang Manharlal Ajmera
Data last updated:
Devang Manharlal Ajmera has 16 years in corporate governance. Holds Director role. Currently with 4 companies, including Vardhman Chemtech Limited and Kinvan Private Limited. Formerly with 3 companies, such as Kelter Care Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹568 Cr; the largest is Dpb Pharmaceuticals Limited at ₹223 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dpb Pharmaceuticals Limited U24304MH2018PLC308316 | Director | 20 Apr 2018 | 2018 | ₹223 Cr (FY 2024) | Active |
 Vardhman Chemtech Limited U24117CH1996PLC018656 | Director | 02 Feb 2021 | 1996 | ₹209 Cr (FY 2025) | Active |
 Kinvan Private Limited U24100HP2020PTC011851 | Director | 10 Oct 2020 | 2020 | ₹136 Cr (FY 2025) | Active |
| Dpb Antibiotics Private Limited U51397CH2010PTC046352 | Director | 27 Mar 2010 | 2010 | ₹10,000 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Kelter Care Pharma Private Limited U24232PB2015PTC039463 | Director | 18 May 2015 | 2015 | ₹70.2 Lakh (FY 2022) | Active |
| Bodhitree Life Sciences Limited U33119PB2020PLC051477 | Director | 24 Jul 2020 | 2020 | – | Strike Off |
 Parth Antibiotics Private Limited U51397MH2009PTC197201 | Director | 21 Nov 2009 | 2009 | ₹3.13 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devang Manharlal Ajmera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devang Manharlal Ajmera
Devang Manharlal Ajmera has 16 years in corporate governance. Holds Director role. Currently with 4 companies, including Vardhman Chemtech Limited and Kinvan Private Limited. Formerly with 3 companies, such as Kelter Care Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹568 Cr; the largest is Dpb Pharmaceuticals Limited at ₹223 Cr (FY 2024).
Devang Manharlal Ajmera is associated with 4 companies as Director, including Dpb Pharmaceuticals Limited (₹223 Cr), Vardhman Chemtech Limited (₹209 Cr), Kinvan Private Limited (₹136 Cr).
Devang Manharlal Ajmera has expertise in Technology, General Business.
Devang Manharlal Ajmera has 16 years in corporate governance.
By reported revenue, the largest current company of Devang Manharlal Ajmera is Dpb Pharmaceuticals Limited, with revenue of ₹223 Cr (FY 2024).
The 4 current companies of Devang Manharlal Ajmera that report revenue have a combined latest revenue of ₹568 Cr.
Devang Manharlal Ajmera currently holds positions at 4 companies: Dpb Pharmaceuticals Limited (₹223 Cr), Vardhman Chemtech Limited (₹209 Cr), Kinvan Private Limited (₹136 Cr), Dpb Antibiotics Private Limited (₹10,000).